This HTML5 document contains 37 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n12http://linked.opendata.cz/resource/drugbank/drug/DB09007/identifier/drugbank/
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
foafhttp://xmlns.com/foaf/0.1/
n9http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n11http://linked.opendata.cz/resource/drugbank/drug/DB09007/identifier/wikipedia/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n7http://www.drugs.com/international/
n13http://linked.opendata.cz/resource/drugbank/drug/DB09007/identifier/kegg-drug/

Statements

Subject Item
n2:DB09007
rdf:type
n3:Drug
n3:description
Chlorphenoxamine (Phenoxene) is an antihistamine and anticholinergic used as an antipruritic and antiparkinsonian agent.
n3:group
withdrawn
owl:sameAs
n9:DB09007
dcterms:title
Chlorphenoxamine
adms:identifier
n11:Chlorphenoxamine n12:DB09007 n13:D07198
n3:synthesisReference
U.S. Patent 2,785,202.
foaf:page
n7:chlorphenoxamine.html
n3:IUPAC-Name
n4:271B644E-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B6454-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B6453-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B6450-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B6451-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B6452-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B644C-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B644A-363D-11E5-9242-09173F13E4C5 n4:271B644D-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B644B-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B645A-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B645B-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B6455-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B6456-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B6458-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B6457-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B6459-363D-11E5-9242-09173F13E4C5
n3:casRegistryNumber
77-38-3
n3:Bioavailability
n4:271B645F-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B6461-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B6462-363D-11E5-9242-09173F13E4C5
n3:Melting-Point
n4:271B6463-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B645E-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B645D-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B6460-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B644F-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B645C-363D-11E5-9242-09173F13E4C5